Eric Schadt's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 100,000 Class A Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on May 20, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, President & Chief R&D Officer | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 20 May 2022 | 100,000 | 243,380 | - | 1.9 | 192,480 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, President & Chief R&D Officer | Sale of securities on an exchange or to another person at price $ 2.18 per share. | 28 Apr 2022 | 35,899 | 143,380 | - | 2.2 | 78,274 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 78,812 | 1,024,563 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 78,812 | 179,279 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 635,368 | 635,368 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 365,972 | 365,972 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 28 Jan 2022 | 29,100 | 100,467 | - | 2.8 | 82,667 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 78,812 | 129,567 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 78,812 | 1,103,375 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 223,557 | 223,557 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 201,474 | 201,474 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 197,394 | 197,394 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 83,716 | 83,716 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 35,012 | 35,012 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 78,812 | 1,182,187 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 78,812 | 78,812 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 25 Oct 2021 | 33,332 | 45,480 | - | 7.5 | 251,323 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,260,999 | 1,260,999 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 840,666 | 840,666 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 2,564,847 | 2,564,847 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 2,311,488 | 2,311,488 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 2,264,674 | 2,264,674 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 960,472 | 960,472 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eric Schadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 401,699 | 401,699 | - | - | Employee Stock Option (Right to Buy) |